2-hydroxypropyl-β-cyclodextrin is the active component in a triple combination formulation for treatment of Niemann-Pick C1 Disease

Niemann-Pick type C1 (NPC1) disease is a fatal neurovisceral disease for which there are no FDA approved treatments, though cyclodextrin (HPβCD) slows disease progression in preclinical models and in an early phase clinical trial. Our goal was to evaluate the mechanism of action of a previously desc...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biochim Biophys Acta Mol Cell Biol Lipids
Main Authors: Davidson, Jessica, Molitor, Elizabeth, Moores, Samantha, Gale, Sarah E., Subramanian, Kanagaraj, Jiang, Xuntian, Sidhu, Rohini, Kell, Pamela, Zhang, Jesse, Fujiwara, Hideji, Davidson, Cristin, Helquist, Paul, Melancon, Bruce J., Grigalunas, Michael, Liu, Gang, Salahi, Farbod, Wiest, Olaf, Xu, Xin, Porter, Forbes D., Pipalia, Nina H., Cruz, Dana L., Holson, Edward B., Schaffer, Jean E., Walkley, Steven U., Maxfield, Frederick R., Ory, Daniel S.
Formato: Artigo
Idioma:Inglês
Publicado em: 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6679735/
https://ncbi.nlm.nih.gov/pubmed/31051283
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbalip.2019.04.011
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados